GrantAdler » NEWS & UPDATES

GrantAdler Receives Keystone Innovation Zone Grant

admin — Tue, 13 Jul 2010 19:17:45 +0000

GrantAdler Corporation has received another $15,000 Keystone Innovation Zone Grant from the State of Pennsylvania. The program, managed locally by the Lehigh Valley Economic Development Corporation, was one of the state-funded incentives that motivated GrantAdler to move its operations from Illinois to Bethlehem, PA.

GrantAdler to Exhibit at SIR in Tampa, FL March 13-18, 2010

admin — Thu, 04 Feb 2010 00:39:33 +0000

GrantAdler announces it will exhibit at this year’s SIR meeting in Tamps, FL Booth 1901. GrantAdler will launch the Rhapsody CT+ Power Port w/SurePlace High-Integrity Catheter System during the meeting. GrantAdler will be holding lunches and dinners during the event to share benefits and features of the product. Please contact your sales professional for specific dates and times if interested.

GrantAdler Receives Keystone Innovation Zone Grant

admin — Tue, 22 Dec 2009 05:01:13 +0000

GrantAdler Corporation has received a $15,000 Keystone Innovation Zone Grant from the State of Pennsylvania. The program, managed locally by the Lehigh Valley Economic Development Corporation, was one of the state-funded incentives that motivated GrantAdler to move its operations from Illinois to Bethlehem, PA.

GrantAdler develops medical implants called ports. A port sits under the skin to make it more convenient for healthcare providers to inject medicines into patients who, for example, are undergoing chemotherapy.

Source: The Morning Call, Bethlehem, PA. October 17, 2009.

GrantAdler Receives $100,000 Ben Franklin Grant

admin — Mon, 21 Dec 2009 05:01:57 +0000

GrantAdler Corporation has received a $100,000 investment from Ben Franklin Technology Partners of Northeastern Pennsylvania as part of Ben Franklin’s program to improve the economic future of Pennsylvania by building partnerships with high-growth companies that develop and apply technology for a competitive advantage.

The $100,000  investment will help GrantAdler complete development of a new vascular access port and support its expanding sales and distribution efforts. GrantAdler is developing and producing a new line of implantable products that allow easier, catheterized access to blood vessels for a variety of procedures.

The company’s initial focus is vascular access for administering chemotherapy drugs and for conducting kidney dialysis.

GrantAdler’s first product, Rhapsody^® CT+, which received FDA approval in 2007, has unique design features that make it competitive in the chemotherapy infusion-port market.

Source: November 18, 2009 Ben Franklin News